Scgb2b15, a member of the secretoglobin family, holds a crucial role in cellular processes related to secretoglobin function. This includes regulatory mechanisms associated with cell differentiation, glucocorticoid signaling, growth factor pathways, and secretoglobin-related processes. The multifaceted nature of Scgb2b15 makes it a key participant in ensuring the proper regulation of diverse cellular functions. The activation of Scgb2b15 involves intricate interactions with various chemicals that impact different cellular processes. Retinoic acid, for example, indirectly activates Scgb2b15 by promoting cell differentiation, influencing its expression and function in secretoglobin-related processes. Dexamethasone, a glucocorticoid receptor agonist, up-regulates Scgb2b15 by activating the glucocorticoid receptor, affecting its expression in response to glucocorticoid signaling. Epidermal Growth Factor (EGF) and tretinoin contribute to Scgb2b15 activation by influencing downstream signaling pathways and promoting cell differentiation, respectively. Glucagon and forskolin elevate cAMP levels, indirectly up-regulating Scgb2b15 and potentially impacting its expression in secretoglobin-related processes.
Trichostatin A, a histone deacetylase inhibitor, modulates chromatin structure, indirectly up-regulating Scgb2b15 and influencing its role in secretoglobin-related processes. Nicotinic acid, as a precursor of NAD+, and GSK621, an AMP-activated protein kinase (AMPK) inhibitor, also influence Scgb2b15 expression by modulating cellular NAD+ levels and energy balance, respectively. Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma (PPARγ), and SB203580, a p38 MAPK inhibitor, indirectly impact Scgb2b15 by activating PPARγ and dampening the p38 MAPK signaling pathway. SB431542, an inhibitor of TGF-β type I receptor, modulates TGF-β signaling, potentially impacting Scgb2b15 expression and function in secretoglobin-related processes. In summary, Scgb2b15 emerges as a central player in the complex orchestration of cellular processes, with its activation intricately linked to the modulation of various cellular pathways. The diverse range of chemicals influencing Scgb2b15 reflects its significance in ensuring the proper regulation of secretoglobin-related functions and highlights its potential as a key target for further investigations in cellular and molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulator of cell differentiation. Indirectly activates Scgb2b15 by promoting the differentiation of target cells, potentially influencing its expression and function in secretoglobin-related processes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist. Indirectly up-regulates Scgb2b15 by activating the glucocorticoid receptor, potentially influencing its expression and function in response to glucocorticoid signaling pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor. Modulates chromatin structure, indirectly up-regulating Scgb2b15 and affecting its role in secretoglobin-related processes. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $62.00 $124.00 | 1 | |
Precursor of NAD+. Indirectly influences Scgb2b15 by modulating cellular NAD+ levels, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Peroxisome proliferator-activated receptor gamma (PPARγ) agonist. Indirectly influences Scgb2b15 by activating PPARγ, potentially impacting its expression and function in secretoglobin-related processes. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor. Indirectly up-regulates Scgb2b15 by dampening the p38 MAPK signaling pathway, potentially influencing its expression and function in secretoglobin-related processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibitor of TGF-β type I receptor. Indirectly influences Scgb2b15 by modulating TGF-β signaling, potentially impacting its expression and function in secretoglobin-related processes. | ||||||